<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02996149</url>
  </required_header>
  <id_info>
    <org_study_id>PV-5379</org_study_id>
    <nct_id>NCT02996149</nct_id>
  </id_info>
  <brief_title>Endoscopic Lung Volume Reduction Coil Treatment in Patients With Chronic Hypercapnic Respiratory Failure</brief_title>
  <official_title>Endoscopic Lung Volume Reduction Coil Treatment in Patients With Chronic Hypercapnic Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <brief_summary>
    <textblock>
      Endoscopic lung volume reduction coil treatment is a treatment option for selected patients
      with severe emphysema. In the advanced stages, emphysema may lead to chronic hypercapnic
      respiratory failure. In this observational study the safety and efficacy of endoscopic lung
      volume reduction coil treatment in patients with chronic hypercapnic respiratory failure is
      evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in PaCO2</measure>
    <time_frame>3 months after endoscopic lung volume reduction (ELVR)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in PaCO2</measure>
    <time_frame>6 and 12 months after ELVR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in FEV1</measure>
    <time_frame>3, 6 and 12 months after ELVR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in vital capacity</measure>
    <time_frame>3, 6 and 12 months after ELVR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in residual volume</measure>
    <time_frame>3, 6 and 12 months after ELVR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in 6-minute walk distance</measure>
    <time_frame>3, 6 and 12 months after ELVR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life (St. George's Respiratory Questionnaire, SGRQ)</measure>
    <time_frame>3, 6 and 12 months after ELVR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in BMI</measure>
    <time_frame>3, 6 and 12 months after ELVR</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Emphysema</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic lung volume reduction coil treatment</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe emphysema and chronic hypercapnic respiratory failure, in whom
        endoscopic lung volume reduction coil treatment is performed
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with emphysema (chronic obstructive pulmonary disease with forced expired
             volume in one second (FEV1) &lt; 50% predicted and residual volume (RV) ≥ 200% predicted)
             in whom endoscopic lung volume reduction coil treatment is performed

          -  Chronic hypercapnic respiratory failure (PaCO2 ≥ 50 mmHg)

          -  Informed consent

        Exclusion Criteria:

          -  Therapeutic anticoagulation

          -  Anti-platelet therapy exceeding the use of acetylsalicylic acid

          -  Severe pulmonary hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Klose</last_name>
      <phone>+4940741054970</phone>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2016</study_first_submitted>
  <study_first_submitted_qc>December 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2016</study_first_posted>
  <last_update_submitted>December 16, 2016</last_update_submitted>
  <last_update_submitted_qc>December 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Dr. Hans Klose</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

